癌症转移:分子机制和临床观点
Sameer Ullah Khan1, Kaneez Fatima2, Fayaz Malik2
1The University of Texas MD Anderson Cancer Center, Division of Genitourinary Medical Oncology, Holcombe Blvd, Houston, TX 77030, USA; Division of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Jammu and Kashmir, India.
Pharmacology & therapeutics
|September 3, 2023
概括
癌症转移涉及复杂的分子事件和支持性瘤微环境 (TME). 本综述详细介绍了使癌细胞存活和殖民的途径,结合了微生物组和神经系统等新型因素.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 转移性进展和治疗不响应是致命癌症结局的关键决定因素.
- 癌细胞传播需要获得的转移性质和支持性瘤微环境 (TME).
- 癌细胞在转移期间的生存包括克服脱离,血管内旅行和殖民挑战.
研究的目的:
- 审查那些促进癌细胞转移的复杂的细胞内和细胞外信号通路.
- 将新兴的转移调节器纳入目前对转移过程的理解.
- 为促进癌细胞扩散和殖民的分子事件提供全面的概述.
主要方法:
- 文献综述和现有癌症转移研究的综合.
- 对分子事件,信号通路和转移所涉及的细胞过程的分析.
- 整合影响转移的新型因素,包括免疫微环境,微生物组,细胞死亡和神经系统.
主要成果:
- 确定了导致转移的复杂分子事件,涉及癌细胞内在特性和TME.
- 详细介绍了癌细胞在传播过程中生存和生长所需的一系列事件,包括脱离,静脉内生存和殖民.
- 突出了细胞内和细胞外信号通路在克服无菌和免疫监测等障碍中的作用.
- 强调新兴的转移调节器,如免疫微环境,微生物组,亚致命细胞死亡和神经系统.
结论:
- 癌症转移是一个多方面的过程,由复杂的分子信号驱动,并受到瘤微环境的影响.
- 了解这些复杂的途径对于开发针对转移性癌症的有效治疗策略至关重要.
- 新出现的因素代表了未来研究和转移治疗临床干预的新目标和考虑.
更多相关视频
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


